Sort   by:  
 Page size 
UnknownPatient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.
Not available
S-EPMC4876313 | biostudies-literature
UnknownQuality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.
Not available
S-EPMC6410892 | biostudies-literature
UnknownEvolocumab in metastatic castration-resistant prostate cancer: study protocol for a single-arm, phase II trial, and initial experience with use of a validated lipid biomarker to direct therapy.
Not available
S-EPMC11650517 | biostudies-literature
UnknownExome Sequencing and the Management of Neurometabolic Disorders.
Not available
S-EPMC4983272 | biostudies-literature
UnknownHealth-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
Not available
S-EPMC8906451 | biostudies-literature
Sort   by:  
 Page size